Admission: Wellnex Life Plc
Wellnex Life Plc (Wellnex) is an Australian incorporated company based in Melbourne, Victoria, that focuses on developing, licensing, marketing and distributing consumer healthcare and pharmaceutical products. These products are available through leading retailers and wholesalers across Australia, including Coles, Woolworths, Chemist Warehouse, Sigma and Symbion. One of the Company's brands 'Mr Bright', is also available in the UK through retailers Superdrug and TK Maxx. Wellnex was officially listed on the Australian Stock Exchange 14 March 2017.
Wellnex’s business focuses on bringing innovative brands and products to the growing consumer healthcare market. Its products are available in all major pharmacy and grocery retailers in Australia. This has enabled the company to build strong partnerships with major players in the industry, including Australia’s largest pharmacy retailer, Chemist Warehouse, and Haleon plc, one of the world’s leading consumer healthcare companies. Wellnex procures the manufacturing of its products for distribution by third parties, including Haleon plc (formerly part of the GlaxoSmithKline group), and Arrotex Pharmaceuticals Pty Limited, Australia's largest generic over-the-counter medicine company.
Crowe's role and team
Crowe acted as reporting accountant on the transaction, with the capital markets team led by Paul Blythe, Ferdia McCarville and Jon Peña. The tax due diligence was undertaken locally by Crowe Australia (an affiliate of Findex), led by Anthony Patrk and David Penpraze.
Client quote
"Crowe’s Capital Markets team offered us valuable support and advice on our AIM admission and the Board appreciated their commercial and professional approach. The Group’s placing and admission to AIM offers us an exciting opportunity for expansion. We would highly recommend Crowe to companies looking to perform secondary listings in London."
George Karafotias, CEO, Wellnex Life Plc
